SciSparc Awarded Patent for Key Technology Across Various Industries
SciSparc Ltd. (Nasdaq: SPRC) has recently solidified its position in the pharmaceutical industry with the completion of the granting and validation process for its core-Technology patent in certain European countries. The patent covers combinations of cannabinoids and n-acylethanolamines, aligning seamlessly with the company’s proprietary technology designed to enhance the safety of cannabinoids while maintaining their…